CT-P39 is Just as Effective as Omalizumab for Chronic Spontaneous Urticaria TreatmentByMarie Bosslett, Assistant EditorJanuary 23rd 2025According to a phase 3 study, the omalizumab biosimilar saw comparable results with a good safety profile.